Singhi Sunit C, Reddy Thimmapuram C S, Chakrabarti Arunloke
Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pediatr Crit Care Med. 2004 Jul;5(4):369-74. doi: 10.1097/01.pcc.0000123550.68708.20.
To examine the incidence, epidemiology, and clinical characteristics of candidemia in a pediatric intensive care unit.
Retrospective cohort study.
Pediatric intensive care unit of a tertiary care teaching and referral hospital in north India.
All patients with candidemia from March 1993 to December 1996.
Patient-related data were analyzed to study candidemia in relation to reason for fungal culture, underlying medical conditions, predisposing factors, Candida isolates, antimicrobial and antifungal treatment, and deaths.
Sixty-four patients with candidemia were identified. The Candida species isolated were Candida tropicalis (48.4%), C. albicans (29.7%), C. guillermondii (14.1%), C. krusei (6.3%), and C. glabrata (1.6%). Thirty-three patients were detected by a high-risk surveillance blood culture, whereas 31 patients were detected while undergoing septic workup. Sixteen (25%) patients were asymptomatic; they recovered without any antifungal therapy and without any sequelae. Of 48 symptomatic patients, 11 died before institution of antifungal therapy; 37 received oral itraconazole (10 mg.kg(-1).day(-1)). Seven (19%) of these 37 patients died. Those who recovered had sterile culture on average by day 14 (range, 4-30) and received the antifungal therapy on average for 24 days (range, 9-42 days). Overall mortality rate was 28.1%, and bivariate analysis showed significant association with Pediatric Risk of Mortality score (p =.0001), presence of symptoms (p =.003), isolation of nonalbicans Candida in general (p =.04) and C. tropicalis specifically (p =.001), and failure to give presumptive antifungal therapy (p =.055). On multivariate analysis, Pediatric Risk of Mortality score and isolation of C. tropicalis were the only significant predictors of mortality.
Nonalbicans Candida accounted for 70% of candidemia in a pediatric intensive care unit. High-risk surveillance blood cultures aided diagnosis in about half the patients. Severity of illness and isolation of C. tropicalis were significant predictors of mortality.
研究儿科重症监护病房念珠菌血症的发病率、流行病学及临床特征。
回顾性队列研究。
印度北部一家三级医疗教学及转诊医院的儿科重症监护病房。
1993年3月至1996年12月期间所有念珠菌血症患者。
分析患者相关数据,以研究念珠菌血症与真菌培养原因、基础疾病、易感因素、念珠菌分离株、抗菌及抗真菌治疗以及死亡情况之间的关系。
共识别出64例念珠菌血症患者。分离出的念珠菌种类有热带念珠菌(48.4%)、白色念珠菌(29.7%)、季也蒙念珠菌(14.1%)、克柔念珠菌(6.3%)和光滑念珠菌(1.6%)。33例患者通过高危监测血培养检测出,31例患者在进行败血症检查时检测出。16例(25%)患者无症状;未经任何抗真菌治疗且无任何后遗症而康复。48例有症状的患者中,11例在开始抗真菌治疗前死亡;37例接受口服伊曲康唑(10mg·kg⁻¹·d⁻¹)治疗。这37例患者中有7例(19%)死亡。康复患者的培养物平均在第14天(范围4 - 30天)转阴,抗真菌治疗平均持续24天(范围9 - 42天)。总体死亡率为28.1%,双变量分析显示与儿科死亡风险评分(p = 0.0001)、症状出现(p = 0.003)、非白色念珠菌总体分离情况(p = 0.04)及热带念珠菌分离情况(p = 0.001)以及未给予推测性抗真菌治疗(p = 0.055)存在显著相关性。多变量分析显示,儿科死亡风险评分和热带念珠菌分离情况是死亡率的唯一显著预测因素。
在儿科重症监护病房,非白色念珠菌占念珠菌血症的70%。高危监测血培养帮助诊断了约一半的患者。疾病严重程度和热带念珠菌分离情况是死亡率的显著预测因素。